Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of...
Disease
London, United Kingdom--(Newsfile Corp. - September 29, 2025) - The 2025 Global Forum of the European Group on Graves' Orbitopathy...
LAS VEGAS, May 20, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner,...
